Whereas the pro-apoptotic BCL-2 mRNA level was significantly reduced in melanoma DPG exposed cells compared to control cells (0.51 vs. 1.07 AUs, p-value = 0.0018) (Figure 1F). This evidence concerns the gene BCL2 and melanoma.